迈向干细胞移植前抗HLA抗体患者免疫风险的定义。 - Suppr

Suppr

超能文献

Toward a definition of immunological risk for patients with anti-HLA antibodies before stem cell transplantation.

作者信息

Crocchiolo Roberto

机构信息

Servizio di Immunoematologia e Medicina Trasfusionale, ASST Grande Ospedale Metropolitano, Niguarda, Milan, Italy.

出版信息

Blood Transfus. 2024 Mar;22(2):93-95. doi: 10.2450/BloodTransfus.630. Epub 2023 Sep 21.

DOI:10.2450/BloodTransfus.630

PMID:37847209

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10920066/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1701/10920066/5db104f67c18/BLT-22-093_g001.jpg

相似文献

Toward a definition of immunological risk for patients with anti-HLA antibodies before stem cell transplantation.

Blood Transfus. 2024 Mar;22(2):93-95. doi: 10.2450/BloodTransfus.630. Epub 2023 Sep 21.

Donor specific anti-HLA antibodies in hematopoietic stem cell transplantation. Single Center prospective evaluation and desensitization strategies employed.

Blood Transfus. 2024 Mar;22(2):157-165. doi: 10.2450/BloodTransfus.464. Epub 2023 Sep 21.

The role of anti-HLA antibodies in hematopoietic stem cell transplantation.

Biol Blood Marrow Transplant. 2011 Nov;17(11):1585-8. doi: 10.1016/j.bbmt.2011.06.004. Epub 2011 Jun 16.

Hematopoietic cell-based and non-hematopoietic cell-based strategies for immune tolerance induction in living-donor renal transplantation: A systematic review.

Transplant Rev (Orlando). 2023 Dec;37(4):100792. doi: 10.1016/j.trre.2023.100792. Epub 2023 Aug 19.

Combination treatment of rituximab and donor platelets infusion to reduce donor-specific anti-HLA antibodies for stem cells engraftment in haploidentical transplantation.

J Clin Lab Anal. 2020 Jul;34(7):e23261. doi: 10.1002/jcla.23261. Epub 2020 Feb 28.

High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation.

Transplantation. 2009 Oct 27;88(8):1019-24. doi: 10.1097/TP.0b013e3181b9d710.

Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation.

Blood. 2011 Nov 24;118(22):5957-64. doi: 10.1182/blood-2011-06-362111. Epub 2011 Oct 3.

Immune modulation to prevent antibody-mediated rejection after allogeneic hematopoietic stem cell transplantation.

Transpl Immunol. 2011 Sep;25(2-3):153-8. doi: 10.1016/j.trim.2011.06.001. Epub 2011 Jun 21.

Anti-HLA Antibody Levels Are Associated With the Risk of Graft Failure After Allogeneic Hematopoietic Stem Cell Transplant.

Exp Clin Transplant. 2017 Feb;15(Suppl 1):219-223. doi: 10.6002/ect.mesot2016.P99.

Successful Induction of Specific Immunological Tolerance by Combined Kidney and Hematopoietic Stem Cell Transplantation in HLA-Identical Siblings.

Front Immunol. 2022 Jan 31;13:796456. doi: 10.3389/fimmu.2022.796456. eCollection 2022.

引用本文的文献

Successful treatment of refractory donor-specific-human leukocyte antigen-antibody-induced primary graft-failure with daratumumab: A case report.

EJHaem. 2024 Jun 19;5(4):863-866. doi: 10.1002/jha2.936. eCollection 2024 Aug.

本文引用的文献

Donor specific anti-HLA antibodies in hematopoietic stem cell transplantation. Single Center prospective evaluation and desensitization strategies employed.

Blood Transfus. 2024 Mar;22(2):157-165. doi: 10.2450/BloodTransfus.464. Epub 2023 Sep 21.

Histocompatibility assessment in hematopoietic stem cell transplantation: recommendations from the Italian Society for Immunogenetics and Transplantation Biology (Associazione Italiana di Immunogenetica e Biologia dei Trapianti - AIBT).

Blood Transfus. 2024 Jul 12;22(4):338-349. doi: 10.2450/BloodTransfus.495.

Donor-Specific HLA Antibodies Are Associated with Graft Failure and Delayed Hematologic Recovery after Unrelated Donor Hematopoietic Cell Transplantation.

Transplant Cell Ther. 2023 Aug;29(8):493.e1-493.e10. doi: 10.1016/j.jtct.2023.05.014. Epub 2023 May 21.

Treatment With the Combination of Rituximab and Intravenous γ Globulin Is Effective in Promoting Engraftment in Donor-Specific Antibody Positive Patients Receiving Myeloablative Conditioning Haploidentical Stem Cell Transplantation.

Transplant Cell Ther. 2023 Aug;29(8):514.e1-514.e6. doi: 10.1016/j.jtct.2023.05.005. Epub 2023 May 11.

Outcomes of graft failure after umbilical cord blood transplantation in acute leukemia: a study from Eurocord and the Acute Leukemia Working Party of the EBMT.

Bone Marrow Transplant. 2023 Aug;58(8):936-941. doi: 10.1038/s41409-023-02000-9. Epub 2023 May 10.

"Incidence and significance of donor-specific antibodies in haploidentical stem cell transplantation".

Bone Marrow Transplant. 2023 Jun;58(6):680-686. doi: 10.1038/s41409-023-01950-4. Epub 2023 Mar 23.

Effects of donor-specific antibodies on engraftment and long-term survival after allogeneic hematopoietic stem cell transplantation-A systematic review and meta-analysis.

Bone Marrow Transplant. 2023 May;58(5):544-551. doi: 10.1038/s41409-023-01932-6. Epub 2023 Feb 13.

Splenic irradiation combined with plasmapheresis and rituximab: a new option reducing donor-specific antibody in haploidentical hematopoietic stem cell transplantation.

Bone Marrow Transplant. 2023 Feb;58(2):226-228. doi: 10.1038/s41409-022-01868-3. Epub 2022 Nov 19.

Presence of antibodies against HLA class I and class II molecules in children before and after allo-HSCT. Alloantibodies before and after HSCT.

HLA. 2023 Jan;101(1):16-23. doi: 10.1111/tan.14817. Epub 2022 Oct 13.

Treatment of allosensitized patients receiving allogeneic transplantation.

Blood Adv. 2021 Oct 26;5(20):4031-4043. doi: 10.1182/bloodadvances.2021004862.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验